BioSpace News Archive

How Important Is It To Be Passionate About Work?

Do you need to be passionate about work to be happy and successful? Well, if you want to be then here are some facts that you must know to be productive.

March 28, 2018
·
4 min read
Deals

With Cash in Hand, Novartis Could Seek Deal to Bolster Drug Pipeline

Following an agreement to sell its share of a consumer health business unit to GlaxoSmithKline for $13 billion new Novartis Chief Executive Officer Vasant Narasimhan has some excess cash to use to shape the company in the coming years.

March 28, 2018
·
2 min read
·
Alex Keown
Deals

The Big Tease: Takeda Considers Buying Shire

Shire stock prices jumped up to 26 percent on rumors that Takeda Pharmaceuticals was considering a buyout.

March 28, 2018
·
3 min read
·
Mark Terry
Business

Homology Medicines Snags $144 Million IPO

Homology Medicines has raised $144 million in an initial public offering of stock.

March 28, 2018
·
2 min read
·
Alex Keown
Biotech Bay

EnCorps Provides Teaching Path for Seasoned STEM Workers

California-based EnCorps is a program that was developed to address declining student achievement in STEM (science, technology, engineering and math) curriculum.The program looks to bolster STEM teaching.

March 28, 2018
·
3 min read
·
Alex Keown
Career Advice

How to Write a Memorable and Effective Cover Letter

One of the biggest mistakes professionals make during their job search is not submitting a cover letter with their resume. *Cover letters increase a resume’s chance of receiving a Five Star rating by 29%.

March 28, 2018
·
3 min read
·
Porschia Parker
Biotech Bay

Five Deaths in Genentech’s Hemlibra Patients

The Hemophilia Federation of America and the National Hemophilia Foundation announced that they had been contacted by Genentech, a Roche company, about the deaths of five patients receiving Hemlibra (emicizumab-kxwh) for hemophilia A.

March 28, 2018
·
2 min read
·
Mark Terry
FDA

FDA Gives Mylan’s New HIV Drug a Thumbs-Up

The U.S. Food and Drug Administration (FDA) approved Mylan NV’s Symfi (efavirnenz, lamivudine and tenofovir disoproxil fumarate) for adult and pediatric HIV-1 patients.This marks the third HIV approval for the company.

March 28, 2018
·
2 min read
·
Mark Terry
Drug Development

Accelerating the Start of Clinical Trials

In STAT News, Mary Jo Lamberti, a research fellow at the Tufts Center for the Study of Drug Development, unveiled an analysis of the amount of time it takes to initiate a clinical trial.

March 28, 2018
·
2 min read
·
Alex Keown
Business

Celgene and bluebird bio Team Up in New Deal

Celgene and bluebird bio have inked a development and promotion deal for bb2121, bluebird’s B-cell maturation antigen (BCMA) CAR-T therapy for relapsed/refractory multiple myeloma (rrMM).

March 28, 2018
·
2 min read
·
Mark Terry